Hudson Bay Capital Management, L.P. Insider Trading $AKER MyMD Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Hudson Bay Capital Management, L.P..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Hudson Bay Capital Management, L.P.. Hudson Bay Capital Management, L.P. is 10% Owner in Akers Biosciences, Inc. ($AKER) and 10% Owner in CHEM RX CORP ($PMQCU) and in TETRALOGIC PHARMACEUTICALS CORP ($TLOG) and 10% Owner in EnteroMedics Inc ($ETRM) and 10% Owner in Galena Biopharma, Inc. ($GALE) and 10% Owner in Jensyn Acquisition Corp. ($JSYN) and 10% Owner in M I Acquisitions, Inc. ($MACQU) and 10% Owner in Trident Acquisitions Corp. ($TDACU) and 10% Owner in Tenzing Acquisition Corp. ($TZAC) and 10% Owner in Longevity Acquisition Corp ($LOAC) and 10% Owner in AMCI Acquisition Corp. ($AMCI) and Director in SCVX Corp. ($SCVX).

Hudson Bay Capital Management, L.P. in MyMD Pharmaceuticals, Inc.

Trading Symbol: AKER
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Hudson Bay Capital Management, L.P.: 10% Owner
Holdings: 240,305 shares
Current Value: $300,381
Latest Transaction: Mar 03 2020
$AKER Market Capitalization: $6.82M
$AKER Previous Close: $1.25

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Hudson Bay Capital Management, L.P. in MyMD Pharmaceuticals, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AMCI, PMQCU, JSYN, LOACU, AKER, MACQU, RSLS, RVPH, SCVX, SLS, TLOG, TDACU

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 03 2020	AKER	Akers Biosciences, ...	Hudson Bay Capital Management ...	10% Owner	Sell	S	2.81	638	1,793	240,305	240.9 K to 240.3 K (-0.26 %)
Jan 07 2020	AKER	Akers Biosciences, ...	Hudson Bay Capital Management ...	10% Owner	Buy	P	3.02	8,000	24,160	269,243	261.2 K to 269.2 K (+3.06 %)
Jan 07 2020	AKER	Akers Biosciences, ...	Hudson Bay Capital Management ...	10% Owner	Buy	P	3.08	2,700	8,316	261,243	258.5 K to 261.2 K (+1.04 %)
Jan 07 2020	AKER	Akers Biosciences, ...	Hudson Bay Capital Management ...	10% Owner	Buy	P	3.07	7,500	23,025	258,043	250.5 K to 258 K (+2.99 %)
Jan 07 2020	AKER	Akers Biosciences, ...	Hudson Bay Capital Management ...	10% Owner	Buy	P	3.03	3,000	9,090	251,043	248 K to 251 K (+1.21 %)
Jan 07 2020	AKER	Akers Biosciences, ...	Hudson Bay Capital Management ...	10% Owner	Buy	P	3.07	5,000	15,350	248,043	243 K to 248 K (+2.06 %)
Jan 07 2020	AKER	Akers Biosciences, ...	Hudson Bay Capital Management ...	10% Owner	Buy	P	3.02	6,000	18,120	243,043	237 K to 243 K (+2.53 %)
Jan 07 2020	AKER	Akers Biosciences, ...	Hudson Bay Capital Management ...	10% Owner	Buy	P	2.98	20,600	61,388	237,043	216.4 K to 237 K (+9.52 %)
Jan 07 2020	AKER	Akers Biosciences, ...	Hudson Bay Capital Management ...	10% Owner	Buy	P	3.05	6,019	18,358	216,443	210.4 K to 216.4 K (+2.86 %)
Jan 07 2020	AKER	Akers Biosciences, ...	Hudson Bay Capital Management ...	10% Owner	Buy	P	3.10	26,406	81,859	210,424	184 K to 210.4 K (+14.35 %)
Jan 07 2020	AKER	Akers Biosciences, ...	Hudson Bay Capital Management ...	10% Owner	Buy	P	2.97	30,000	89,100	184,018	154 K to 184 K (+19.48 %)
Jan 07 2020	AKER	Akers Biosciences, ...	Hudson Bay Capital Management ...	10% Owner	Buy	P	2.99	50,000	149,500	154,018	104 K to 154 K (+48.07 %)
Jan 07 2020	AKER	Akers Biosciences, ...	Hudson Bay Capital Management ...	10% Owner	Buy	P	2.96	19,353	57,285	104,018	84.7 K to 104 K (+22.86 %)

Page: 1